Momentum Stock Alert!

Art4Love: Emerging growth art company that secures the distribution, leasing
and sales rights of visual art.
OTC: ALVN . PK
Current Price: .70

We Assume Many Of You Like to "Trade the Promotion" and May Have Made Some
Big, Fast Money Doing So. There is a Massive Promotion Underway This Weekend
Apprising Potential Eager Investors of this Emerging Situation. Will it Go
Crazy Monday Morning? Put It On Your Radar Screen Right Now.

Recent Headlines: (Source: Press Releases)

1) Top Sculpture Artist, Lin Evola, Engages Art4Love to Offer $43 Million
Sculpture and Art Collection of Works to the Corporate World- Art4Love
Becomes the Exclusive Representative for World-Renowned Artist

2) A4L GALLERY Premieres First Showing in New York City - "Preview of the
5th
International Florence Biennale" to exhibit the nominated works of Art4Love
artist Gina Brezini

3) Art4Love, Inc. Announces the Opening of New A4L GALLERY in New York City-
"Brick and Mortar" Gallery Transforms Art4Love Into Multi-Channel Art Dealer

Corporate Snapshot: ALVN (Source: News 10/25/05)

Art4Love Inc. (ALVN) is an emerging growth art company that secures the
distribution, leasing and sales rights of visual art. Currently, the Company
has access to the works of 1,200 artists, representing the rights of over
15,000 pieces of original artwork by both established and emerging artists,
and over 80,000 high quality digital images through its partnership
agreements. Offering a comprehensive range of leasing and sales options and
an extensive selection of artwork, the Company provides a
"one-stop/full-service environment" to assist its corporate clients with all
facets of their art needs. In addition, the company offers a complete range
of consulting services including framing, installation, disposition, digital
image licensing, limited edition prints, portraits and commissioned work.
Believing that artwork is an essential element in the office and home
environments, Art4Love's vision is to be a leader in the corporate art
market, which currently allocates $10 billion annually in support of the
arts (American Canvas: The Evolving Cultural Landscape, Jane Alexander, NEA
publication).

_______________

Can You Make Some Fast Money on This One? Put It On Your Radar Now..

Information within this email contains 4rward looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 21B of the
Securities Exchange Act of 1934. Any statements that express or involve
discussions with respect to predictions, expectations, beliefs, plans,
projections, objectives, goals, assumptions or future events or performance
are not statements of historical fact and may be 4rward looking
statements.4rward l0oking statements are based on expectations, estimates
and projections at the time the statements are made that involve a number of
risks and uncertainties which could cause actual results or events to differ
materially from those presently anticipated. The Company is not a reporting
company registered under the Securities Exchange Act of 1934 and therefore
there is limited information available about the company. As with many
microcap st0cks, today's company has disclosable material items you need to
consider in order to make an informed and intelligent decision. These items
include a nominal cash position and nominal revenues in its most recent
quarter. The company is going to need financing.If that financing does not
occur, the company may not be able to continue as a going concern in which
case you could lose your entire investment. Other factors include general
economic and business conditions, the ability to acquire and develop
specific projects, the ability to fund operations and changes in consumer
and business consumption habits and other factors over which the company has
little or no control. The publisher of this newsletter does not represent
that the information contained in this message states all material facts or
does not omit a material fact necessary to make the statements therein not
misleading. All information provided within this email pertaining to
investing, stocks, securities must be understood as information provided and
not investment advice. Any reference to past performance(s) of companies are
specially selected to be referenced based on the favorable performance of
these companies. You would need perfect timing to acheive the results in the
examples given. There can be no assurance of that happening. Remember, as
always, past performance is never indicative of future results and a
thorough due diligence effort, including a review of a company's filings
when available, should be completed prior to investing. The publisher of
this newsletter advises all readers and subscribers to seek advice from a
registered professional securities representative before deciding to trade
in stocks featured within this email. None of the material within this
report shall be construed as any kind of investment advice or solicitation.
Many of these companies are on the verge of bankruptcy. You can lose all
your money by investing in this stock. The publisher of this newsletter is
not a registered in-vestment advis0r. Subscribers should not view
information herein as legal, tax, accounting or in_vestment advice. In
compliance with the Securities Act of 1933, Section 17(b),The publisher of
this newsletter is contracted to receive four hundred twenty five thousand
d0llars from a third party, not an officer, director or affiliate
shareholder for the circulation of this report. Be aware of an inherent
conflict of interest resulting from such compensation due to the fact that
this is a paid advertisement and is not without bias.The party that pays us
has a position in the stock they will sell at any time without notice. This
could have a negative impact on the price of the stock, causing you to lose
money.Their intention is to sell. All factual information in this report was
gathered from public sources, including but not limited to Company Press
Releases. The publisher of this newsletter believes this information to be
reliable but can make no guarantee as to its accuracy or completeness. Use
of the material within this email constitutes your acceptance of these
terms.

PDGT Announces Next Generation Fisker Pro

GEORGETOWN, Mass., Oct. 20 /PRNewswire-FirstCall/ -- Paradigm Tactical Products, a leading provider of non-lethal defense and homeland security solutions to corrections, law enforcement and the security industry, announced today it is developing the next generation of its patented FriskerPro®, the world's only hand worn metal detection device. The FriskerPro is worn like a glove and improves upon the police pat-down search technique, by eliminating direct contact with the suspect. Unlike traditional 'wand' style detectors, the FriskerPro allows officers to retain full use of their hands, improving the officer's ability to respond to events as they unfold.

Since the initial release of the original FriskerPro in 2002, thousands of units have been sold.

Based on end-user feedback, the FriskerPro is being redesigned to be lighter, more durable, and with increased functionality to meet evolving customer needs. These enhancements will allow even greater application of the Frisker Pro's patented technology to potential non security industry markets that may include schools or live performance venues. The Company anticipates the new version of the Frisker Pro to be available in 2006.

Daniel O'Riordan, Chairman, President and Chief Executive Officer of Paradigm Tactical Products, said, "User response to the FriskerPro has been extremely positive, both from current and prospective end-users and channel partners. Police officers are perhaps the largest market for the FriskerPro. With the national total police equipment budget in the $7-8 billion range, the increasing market acceptance and demand for our product represents potential growth opportunities for the Company. We anticipate that the new version of the FriskerPro will accelerate sales into 2006 and beyond."

About Paradigm Tactical Products
Paradigm Tactical Products, based in Georgetown , Massachusetts , is a leading provider of non-lethal defense and homeland security solutions to corrections, law enforcement and security industry. The Company acquired the exclusive transferable license to manufacture, market and sell the FriskerPro, the only patented, hand worn metal detection device. As the heightened attentiveness to terrorist and other security threats continue to increase, Paradigm Tactical is ramping up its production and marketing efforts to meet the higher demand for security and inspection systems. The Company has sold over 2,000 FriskerPro hand worn metal detectors and the FriskerPro is currently being used or tested by 13 Federal departments and agencies, six state law enforcement and correctional agencies and eight local agencies

USA Small-cap Review

WE TOLD YOU TO WATCH!!!
IT'S STILL NOT TOO LATE!
TRADING ALERT!!!

Timing is everything!!!

Profits of 200-400% EXPECTED TRADING

COMPANY: China Digital Media Corporation
SYMB0L: CDGT.OB
Opening Price: 1.70

About China Digital Media Corporation

China Digital Media Corporation (OTC Bulletin Board: CDGT - News)
focuses its business in three main areas: Cable Television Operations,
Programs Production and Advertising Sales. Arcotect (Guangzhou)
Technology Limited, a wholly owned subsidiary of CDGT in China,
is the sole contractor and operator of digital television services
in Nanhai, a city with 400,000 cable television subscribers.
As of today, Nanhai's cable television operation provides
130 television channels which comprises of 38 basic channels
and 92 pay channels. The pay channels are categorized
into various value added packages. The digital broadcasting system
could offer more than 800 digital channels of pay television programs
and value added multimedia services. The Group is seeking
to establish similar models elsewhere in China.

Yes, it is Starting To MOVE, Friday could be HUGH!!!
10 Day Projectiont: $4-$6

Are You A Penny stock Fan?

EXPLOSIVE PICK FOR OUR MEMBERS.
T R A D I N G A L E R T!
Date: 20 Oct 2005
Company: Allixon International Corporation
Symbol: AXCP . PK
Price: $3.85
3 to 5 Days Projection: $6.00 - $7.00
7 to 9 Days: $8.00 - $10.00

Allixon International Corporation is a leading provider
of RFID middleware and mobile Internet solutions
for device computing. Allixon combines its products,
expertise, partnerships and integration capability
into solutions for a wide range of device computing
applications, including RFID middleware
and m-banking solution. Allixon's products based
on ubiquitous technologies direct companies looking
to tap into the wealth of data captured by networked devices
such as RFID readers or handhelds to extend the quality
of information to any device where they want.

We give it to you again as a gift. This company is doing
incredible things. They have cash and have made great
strategic aquisitions. Current price is $3.85.
Short term projection is $6. This company has dropped
big new's in the past. Who's to say they don't have
another big one.

Play Small-Caps for Big Gains

An Investor ALERT is being issued starting right NOW.
Keep your eyes glued Wednesday 19th , 2005 on CHMS...
EXPLOSIVE PICK FOR OUR MEMBERS!
!!! THIS IS OUR 4th Quarter LOCK OF THE YEAR !!!
OUR HOT PICK IS CHMS.

SYMBOL: CHMS
CURRENT PRICE: $.49
12 Day Trading Projection: $1.75
STATUS: (BUY)
RATING: 3-STAR

WE GIVE IT TO YOU AS A GIFT AND THIS IS WHY !!!

About China Mobility Solutions Inc.

China Mobility Solutions (OTC Bulletin Board: CHMS - News),
a pioneer in developing Short Message Services (SMS)
as a primary advertising medium in China, provides mobile marketing,
branding and enterprise solutions to its rapidly expanding client base
of Small and Medium Enterprises (SME). Through proprietary profit
sharing agreements, the company's advertising audience includes
SMS subscribers from China Mobile, China Unicom and China Telecom.

Investor Alert

Looking for a company with some good news? Here's one!

Date: 14 Oct 2005
Company: Worldwide Biotech & Pharmaceutical Group
Stock: WWBP . OB
Current Price: $1.80
Short Term Target: $3
12month Target: $5 - $7

---

WWBP Receives Positive Response at China Economic Summit
for its HCV (Hepatitis C Virus) Technology in Beijing

XI'AN, China, /Xinhua-PRNewswire/ -
Worldwide Biotech & Pharmaceutical Group
(OTC Bulletin Board: WWBP - News; "WWBP") successfully introduced
its Chinese Golden Medal patented invention -
"the Intact Hepatitis C Virus (HCV) and Method
for Culturing HCV in Vitro by Cell Culture" to conventioneers
when Ms Wenxia Guo, CEO and President of WWBP,
attended the China Economic Summit held in Beijing.

As a core part of the 8th China Beijing International High-tech Exposition,
which is held annually, the China Economic Summit mainly focuses
on high-tech innovation and China's sustainable economic growth.
Because high-tech innovation was the main theme of the Summit,
WWBP seized the opportunity by introducing a leading invention
for medical technology named, HCV (Hepatitis C Virus),
and more importantly, by this chance WWBP has won an initial success
for its recognition and reputation. This Economic Summit has provided
WWBP with a platform to introduce its achievement in HVC technology
to all the attendants of the Summit across the world.

In fact, China is harboring a third of all chronic hepatitis B (HBV)
sufferers and a fourth of chronic hepatitis C (HCV) sufferers,
120 million and 41 million people respectively.
With this huge potential market, it is clear that the situation
WWBP faces is prosperous and but also competitive.

"We are very thankful for being given such a great opportunity
to attend the Economic Summit. The theme of this summit
which is around innovation let us know that it's the right time
for WWBP to quicken the steps ahead to high-end technology development,"
said Wenxia Guo, CEO and President of WWBP, "WWBP is a biotech company
and the technological innovation is our core element.
With this predominance, WWBP will quicken the stages
of HCV development with all our strength."

About Worldwide Biotech & Pharmaceutical (Group) Co., Ltd.

Worldwide Biotech & Pharmaceutical Company ("WWBP") is a hi-tech biotech
company with top-ranking pharmaceutical R&D abilities,
Good Manufacturing Practices (GMP) licensed manufacturing facilities
and a well-established marketing network in China and Southeast Asia.
The product range of WWBP covers Hepatitis C Virus (HCV) products,
diagnostic medicines and Over-The-Counter (OTC) drugs.
WWBP currently possesses of 35,940 square meters of land
and 5,359 square meters of GMP standard facilities.
With strong pharmaceutical R&D abilities especially in the HCV field,
WWBP has been known as the first biotech company in the world
to hold the technology of culturing intact HCV in vitro by cell culture.
Its principle project "the Intact Hepatitis C Virus (HCV) and Method
for Culturing HCV in Vitro by Cell Culture" was awarded
with a Chinese patent by the China Patent Bureau
and the prestigious China Patent Golden Medal
by the World Intellectual Property Organization and China Patent Bureau.
The medal is the only one issued for achievement
in the biomedical sciences during the past 10 years.
WWBP has achieved a GMP production scale level of 10,000 ml
for concentrated HCV material and 10 grams HCV antigen per month,
which is expected to bring WWBP considerable gross sale revenue
each year and greatly strengthen the company's R&D
on anti-HCV drug screen and HCV human vaccine.
WWBP has successfully reached two merger agreements
with pharmaceutical companies in China, all of which have scalable
production
and well-established sales network and the acquiring is expected
to be finished before the end of August 2005.
The acquisitions will strengthen WWBP's R&D abilities
and production scale, as well as extend its marketing network
throughout China and Southeast Asia. WWBP has been working closely
with pharmaceutical research institutes, and has established connections
with both central & local governments.

About the China Economic Summit

The China Economic Summit was held at the Great Hall of the People
in Beijing on May 24, 2005 and, it is a main part
of the 8th China Beijing International High-tech Exposition.
This summit will focus on the following key items: "2005 China Innovation
Year",
"Financial Innovation", "Enterprise Governing and China's Economic
Sustainable Growth." During the summit, a number of famous economists
and entrepreneurs gave a brilliant debate on key areas.

About HCV (Hepatitis C Virus) Technology

HCV is a small, enveloped, single-stranded, blood-borne RNA virus
in the family Flaviviridae. HCV is a major cause of liver disease
in the United States and the world. WWBP has committed a large amount
of cash and resources to the development of its cornerstone technology:
a laboratory method for culturing (growing, propagating)
intact Hepatitis C Virus. After three years of intensive research,
the scientists at WWBP achieved a technological breakthrough
for culturing HCV in vitro, making it the first to overcome
the main hurdle to HCV research and product development.
The breakthrough in establishing a cell culture system for HCV production
and infection by WWBP scientists provides a potentially unlimited source
for HCV and a comprehensive technology platform upon which the Company
can be built. From this Rosetta stone, WWBP hopes to development
new generation HCV diagnostics, new classes of HCV drugs, HCV vaccines
and to be part of the development of next-generation anti-HCV targeted
(gene) therapies.

---

..Whatever you do WATCH WWBP...
WE GIVE IT TO YOU AGAIN AS A GIFT. THIS COMPANY IS DOING INCREDIBLE THINGS.
THAY HAVE CASH AND HAVE MADE GREAT STRATEGIC AQUISITIONS. CURRENT PRICE
$1.80
WORD ON THE SREET IS THIS COULD TAKE OFF AT ANY MOMENT AND DOUBLE. THIS
COMPANY
HAS DROPPED BIG NEW'S IN THE PAST. WHO'S TO SAY THEY DON'T HAVE ANOTHER BIG
ONE.

News

Breaking news alert issue - big news coming.

Allixon International Corporation
A X C P . P K

We give it to you again as a gift. This company is doing
incredible things. They have cash and have made great
strategic aquisitions. Current price is $4.70.
Short term projection is $8. This company has dropped
big new's in the past. Who's to say they don't have
another big one.

UN-AMERICAN, adj. Wicked, intolerable, heathenish.
Bacchus hath drowned more men than Neptune.
As soon as you trust yourself, you will know how to live.
Don't be humble, you're not that great.
Solitude, the safeguard of mediocrity.
I'm just a person trapped inside a woman's body.
Never lie when the truth is more profitable.
You live and learn. Or you don't live long.
How could I lose to such an idiot?
The higher the buildings, the lower the morals.
An intelligence service is, in fact, a stupidity service.
Try to learn something about everything and everything about something.
Wish not so much to live long as to live well.
When the student is ready. . . the lesson appears.
Sing Ho! For the life of a Bear!
Nothing fails like success.
Rest in peace. The mistake shall not be repeated.
Reason and free inquiry are the only effectual agents against error.
Flattery looks like friendship, just like a wolf looks like a dog.
Sanity is a madness put to good use.